HLA-B∗1502–bound peptides: Implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome
Authors:
- Shuen-Iu HungShuen-Iu Hung
- Chiun-Gung JuoCJChiun-Gung Juo
- Ya-Ping LinYLYa-Ping Lin
- Wu-Hsiang FangWFWu-Hsiang Fang
- I.-Hsuan LuILI.-Hsuan Lu
- Shui-Tein ChenSCShui-Tein Chen
- Yuan-Tsong ChenYCYuan-Tsong Chen
- 1 October 2007
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 120 (4) , 870-877
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactionsPharmacogenetics and Genomics, 2006
- A marker for Stevens-Johnson syndrome …: ethnicity mattersThe Pharmacogenomics Journal, 2006
- Major Histocompatibility Complex Class I Molecules Bind Natural Peptide Ligands Lacking the Amino-terminal Binding Residue in VivoJournal of Biological Chemistry, 2001
- Cytotoxicity Is Mandatory for CD8+ T Cell–mediated Contact HypersensitivityJournal of Experimental Medicine, 1999
- T cell immune responses to haptens. Structural models for allergic and autoimmune reactionsToxicology, 1996
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypesCurrent Biology, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Characterization of natural peptide ligands for HLA‐B*4402 and ‐B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA‐B44 heavy chainTissue Antigens, 1994
- Structural heterogeneity in HLA‐B70, a high‐frequency antigen of black populations *Tissue Antigens, 1993